IGF-like Family Member 3: A Promising Drug Target (G388555)

Target Name: IGFL3

NCBI ID: G388555

IGFL3

IGF-like Family Member 3: A Promising Drug Target

IGF-like family member 3 (IGFL3) is a protein that is expressed in various tissues throughout the body. It is a member of the IGF-like family, which includes proteins that are similar to the insulin growth factor (IGF) signaling pathway. This family of proteins plays a crucial role in the growth and development of tissues, including muscles, bones, and organs.

One of the key functions of IGFFL3 is to regulate the activity of the insulin-like growth factor 1 (IGF-1), which is a protein that is produced by the liver and is responsible for promoting cell growth and division. IGFFL3 is able to bind to the IGF-1 receptor, which is a protein that is found on the surface of many different types of cells in the body. This binding allows IGFFL3 to regulate the activity of IGF-1, which in turn can influence the growth and development of tissues.

One of the things that makes IGFFL3 such a promising drug target is its ability to interact with multiple signaling pathways. For example, IGFFL3 has been shown to be involved in a number of different signaling pathways, including the TGF-β pathway and the Wnt pathway. This means that it is possible to target IGFFL3 with a variety of different drugs, which could be useful for treating a wide range of diseases.

In addition to its role in regulating IGF-1 signaling, IGFFL3 is also thought to have a number of potential therapeutic applications. For example, IGFFL3 has been shown to be involved in the development and maintenance of cancer stem cells, which are cells that have the ability to give rise to all of the different types of cells in the body. This suggests that targeting IGFFL3 could be a useful way to treat cancer.

Another potential application of IGFFL3 is its role in the development and treatment of autoimmune diseases. IGFFL3 has been shown to be involved in the regulation of immune cell function, which suggests that it could be a useful target for treatments that are designed to treat autoimmune diseases.

In addition to its potential therapeutic applications, IGFFL3 is also an attractive biomarker for a variety of different diseases. For example, IGFFL3 has been shown to be involved in the development and progression of a number of different diseases, including cancer, autoimmune diseases, and obesity. This suggests that IGFFL3 could be a useful indicator of the severity and progression of these diseases.

Overall, IGFFL3 is a protein that is involved in a number of different signaling pathways and has a wide range of potential therapeutic applications. As more research is done on its role in the development and treatment of various diseases, IGFFL3 is likely to become an increasingly important target for researchers and doctors.

Protein Name: IGF Like Family Member 3

Functions: Potential ligand of the IGFLR1 cell membrane receptor

The "IGFL3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGFL3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets